"Dengue Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent infection with DENGUE VIRUS. These include live-attenuated, subunit, DNA, and inactivated vaccines.
| Descriptor ID |
D053059
|
| MeSH Number(s) |
D20.215.894.899.162
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dengue Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Dengue Vaccines".
This graph shows the total number of publications written about "Dengue Vaccines" by people in this website by year, and whether "Dengue Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 3 | 0 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 12 | 3 | 15 |
| 2018 | 26 | 6 | 32 |
| 2019 | 6 | 1 | 7 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Dengue Vaccines" by people in Profiles.
-
Infectious disease mRNA vaccines and a review on epitope prediction for vaccine design. Brief Funct Genomics. 2021 09 11; 20(5):289-303.
-
Fear, mistrust, and vaccine hesitancy: Narratives of the dengue vaccine controversy in the Philippines. Vaccine. 2021 08 16; 39(35):4964-4972.
-
Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity. Commun Biol. 2021 05 11; 4(1):557.
-
Vaccine development for emerging infectious diseases. Nat Med. 2021 04; 27(4):591-600.
-
Communicating COVID-19 vaccines: lessons from the dengue vaccine controversy in the Philippines. BMJ Glob Health. 2021 03; 6(3).
-
COVID-19 Vaccines: Should We Fear ADE? J Infect Dis. 2020 Nov 13; 222(12):1946-1950.
-
After the honeymoon, the divorce: Unexpected outcomes of disease control measures against endemic infections. PLoS Comput Biol. 2020 10; 16(10):e1008292.
-
Inference on treatment effect modification by biomarker response in a three-phase sampling design. Biostatistics. 2020 07 01; 21(3):545-560.
-
The first licensed dengue vaccine: can it be used in travelers? Curr Opin Infect Dis. 2019 10; 32(5):394-400.
-
Serostatus testing and dengue vaccine cost-benefit thresholds. J R Soc Interface. 2019 08 30; 16(157):20190234.